US Regulation of Pharmaceutical Outcomes Research Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000


  • Laurie B. Burke RPh, MPH

    1. Chief, Evidence Review Branch, Division of Drug Marketing, Advertising and Communications (DDMAC),
      Food and Drug Administration (FDA)
    Search for more papers by this author

  • The views expressed in this article are those of the author and do not represent the official opinion or policy of the Food and Drug Administration.

Address correspondence to: Laurie B. Burke, Chief, Evidence Review Branch, DDMAC, U. S. Food and Drug Administration, 5600 Fishers Lane, Mail Stop HFD-42, Rockville, MD 20857. E-mail:

No abstract is available for this article.